{"id":9198,"date":"2024-12-10T13:41:06","date_gmt":"2024-12-10T12:41:06","guid":{"rendered":"https:\/\/www.sgmo.ch\/?p=9198"},"modified":"2024-12-10T13:42:04","modified_gmt":"2024-12-10T12:42:04","slug":"third-pharmaceutical-company-at-spap","status":"publish","type":"post","link":"https:\/\/www.sgmo.ch\/en\/third-pharmaceutical-company-at-spap\/","title":{"rendered":"Third pharmaceutical company at SPAP"},"content":{"rendered":"<p>On 1 January 2025,<b> iQone<\/b> will become the third pharmaceutical company to join the <b>Swiss Patient Access Program (SPAP)<\/b>. So far, Roche and AstraZeneca are partner companies of SPAP.<\/p>\n<p>As a reminder, the SPAP was launched by the SSMO to enable cancer patients to gain rapid and equal access to off-label use medications that have previously been rejected twice by health insurance companies.<\/p>\n<p>You are welcome to continue submitting <b>your applications to SPAP <\/b>here: https:\/\/www.spap.health\/de\/<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On 1 January 2025, iQone will become the third pharmaceutical company to join the Swiss Patient Access Program (SPAP). So far, Roche and AstraZeneca are partner companies of SPAP. As [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9198","post","type-post","status-publish","format-standard","hentry","category-unkategorisiert"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.sgmo.ch\/en\/wp-json\/wp\/v2\/posts\/9198","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sgmo.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sgmo.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sgmo.ch\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sgmo.ch\/en\/wp-json\/wp\/v2\/comments?post=9198"}],"version-history":[{"count":2,"href":"https:\/\/www.sgmo.ch\/en\/wp-json\/wp\/v2\/posts\/9198\/revisions"}],"predecessor-version":[{"id":9202,"href":"https:\/\/www.sgmo.ch\/en\/wp-json\/wp\/v2\/posts\/9198\/revisions\/9202"}],"wp:attachment":[{"href":"https:\/\/www.sgmo.ch\/en\/wp-json\/wp\/v2\/media?parent=9198"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sgmo.ch\/en\/wp-json\/wp\/v2\/categories?post=9198"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sgmo.ch\/en\/wp-json\/wp\/v2\/tags?post=9198"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}